Trial intelligence / Profile preview

Tamsulosin plus meloxicam for lower urinary tract symptoms due to benign prostatic hyperplasia

IRCT201009304582N4Phase 3Completed

Sponsor
Urology Research Center
Start
Jul 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of tamsulosin and meloxicam in benign prostatic hyperplasia (BPH) and Micturition disorder, sponsored by Urology Research Center. Started Jul 2010; status: completed.

02

Drugs

tamsulosinmeloxicam
03

Conditions

benign prostatic hyperplasia (BPH)Micturition disorder

Beyond the preview

Go deeper on IRCT201009304582N4.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201009304582N4.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call